相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway
Yingxiang Shi et al.
CELLULAR SIGNALLING (2023)
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer
Iolanda Scognamiglio et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness
Farzaneh Darbeheshti et al.
BMC CANCER (2022)
Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients
Nina Petrovic et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
Jhajaira M. Araujo et al.
CANCERS (2022)
LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability
Peng-Ping Li et al.
Aging-US (2021)
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
Yu Wang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes
Jie Li et al.
MOLECULAR CANCER (2021)
Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer
Pengjun Qiu et al.
PLOS ONE (2021)
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
Tian Tian et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
Amal Qattan et al.
GENES (2021)
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2
Heng Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
Dejan Vidovic et al.
CELL DEATH AND DIFFERENTIATION (2020)
Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
Emre Ozgur et al.
CANCER BIOMARKERS (2020)
A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells
Maxine Umeh-Garcia et al.
CANCER RESEARCH (2020)
miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages
Ismael Sanchez-Gonzalez et al.
CANCER RESEARCH (2020)
miR-574-5p attenuates proliferation, migration and EMT in triple-negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis
Ke-Jing Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis
Cheng Zeng et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Antitumour Anthracyclines: Progress and Perspectives
Maristela B. Martins-Teixeira et al.
CHEMMEDCHEM (2020)
Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
Shujun Li et al.
FRONTIERS IN GENETICS (2020)
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Ozge Saatci et al.
NATURE COMMUNICATIONS (2020)
The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer
Xiaying Zheng et al.
MOLECULAR CANCER (2020)
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
Barbara Pasculli et al.
FRONTIERS IN ONCOLOGY (2020)
MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis
Jingyi Wang et al.
CELL DEATH & DISEASE (2020)
Roles of miRNA and IncRNA in triple-negative breast cancer
Juan Xu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer
Ye Du et al.
CELL DEATH & DISEASE (2020)
Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7
Xingping Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
Simona Ruxandra Volovat et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients
Andriani Tsiakou et al.
CLINICAL BIOCHEMISTRY (2019)
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
Fumihiko Urabe et al.
CLINICAL CANCER RESEARCH (2019)
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Ashif Iqubal et al.
LIFE SCIENCES (2019)
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Yueh-Shan Weng et al.
MOLECULAR CANCER (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT
Jun Nie et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2019)
miR-145-5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGFβR2 in breast cancer
Frederik Garcia-Garcia et al.
ONCOLOGY REPORTS (2019)
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
Cheng Wang et al.
BMC CANCER (2019)
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer
Dasom Son et al.
CANCER LETTERS (2019)
MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
Mei Liu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Emerging roles of exosomal miRNAs in breast cancer drug resistance
Hamid Najminejad et al.
IUBMB LIFE (2019)
MicroRNA-126-3p inhibits the proliferation, migration, invasion, and angiogenesis of triple-negative breast cancer cells by targeting RGS3
Zhipeng Hong et al.
ONCOLOGY REPORTS (2019)
Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner
Bing Wang et al.
CURRENT DRUG METABOLISM (2019)
Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
Zahra Bolandghamat Pour et al.
BMC CANCER (2019)
MicroRNA-17 acts as a tumor Chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer
Sumei Wang et al.
CANCER LETTERS (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach
Leimarembi Devi Naorem et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer
Zhi-Dong Lv et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
被撤回的出版物: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression (Retracted article. See vol. 21, 2022)
Rui Yang et al.
MOLECULAR CANCER (2019)
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
Laura Cantini et al.
NUCLEIC ACIDS RESEARCH (2019)
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer
Hong Jia et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression
Xiaoke Hou et al.
ONCOLOGY LETTERS (2019)
GECKO is a genetic algorithm to classify and explore high throughput sequencing data
Aubin Thomas et al.
COMMUNICATIONS BIOLOGY (2019)
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Eduardo Tormo et al.
SCIENTIFIC REPORTS (2019)
microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2
Huijuan Zeng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3
Xiangdong Bai et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer
San-Jian Yu et al.
BMC CANCER (2018)
MicroRNA-493 is a prognostic factor in triple-negative breast cancer
Ling Yao et al.
CANCER SCIENCE (2018)
microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
Xiaowei Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Applications of RNA Indexes for Precision Oncology in Breast Cancer
Liming Ma et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2018)
Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients
Sebastian Niedzwiecki et al.
GINEKOLOGIA POLSKA (2018)
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
Mustafa Kahraman et al.
SCIENTIFIC REPORTS (2018)
Aberrant miRNAs expressed in HER-2 negative breast cancers patient
Cornelia Braicu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer
Qiuju Wu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD
Hongming Song et al.
BMB REPORTS (2018)
MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24
Zhishuang Li et al.
ONCOTARGET (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Rimi Hamam et al.
CELL DEATH & DISEASE (2017)
Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer
Anjana Bhardwaj et al.
ONCOTARGET (2017)
MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer
Jinsei Miyoshi et al.
SCIENTIFIC REPORTS (2017)
Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation
Kai Qu et al.
SCIENTIFIC REPORTS (2017)
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
Hao-Yi Li et al.
BREAST CANCER RESEARCH (2017)
Breast Cancer: Current Molecular Therapeutic Targets and New Players
Siddavaram Nagini
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Brian D. Adams et al.
CANCER RESEARCH (2016)
MiR-502/SET8 regulatory circuit in pathobiology of breast cancer
Ben Liu et al.
CANCER LETTERS (2016)
Decoding the usefulness of non-coding RNAs as breast cancer markers
Maria Amorim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Omics Profiling in Precision Oncology
Kun-Hsing Yu et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4
Lifen Zhao et al.
ONCOLOGY REPORTS (2016)
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Yong Zhao et al.
SCIENTIFIC REPORTS (2016)
Biomarker development in the precision medicine era: lung cancer as a case study
Ashley J. Vargas et al.
NATURE REVIEWS CANCER (2016)
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
Yong Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Identification of novel long non-coding RNAs in triple-negative breast cancer
Xiaokun Shen et al.
ONCOTARGET (2015)
MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
Yancheng Lin et al.
SCIENTIFIC REPORTS (2015)
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Gabriel Eades et al.
MOLECULAR CANCER RESEARCH (2015)
Prognostic and Biological Significance of MicroRNA-127 Expression in Human Breast Cancer
Shaohua Wang et al.
DISEASE MARKERS (2014)
High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
Simone Anfossi et al.
PLOS ONE (2014)
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
Ailbhe M. McDermott et al.
PLOS ONE (2014)
miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6
Jingwen Chen et al.
PLOS ONE (2013)
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
Marcella Cesana et al.
CELL (2011)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
Aoife J. Lowery et al.
BREAST CANCER RESEARCH (2009)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
分享论文
